$45.3 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$455.23 - $706.95The lowest and highst price in the last 52 weeks.
59.85xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$45.3 Billion|
|Enterprise Value||$46 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+7.4%|
|Outstanding Shares||84.8 Million|
|Avg 30 Day Volume||404 Thousand|
|Earnings per Share||$8.72|
|Price to Sales Ratio||14.7|
|Price to Book Ratio||66.17|
|Revenue to Enterprise Value||14.67|
|EBIT to Enterprise Value||50.12|
|Total Debt to Enterprise Value||0.02|
|Debt to Equity||1.13|
|Gross Profit||$1.84 Billion|
|Net Income||$757 Million|
|Quarterly Earnings Growth (YoY)||+19.8%|
|Return on Equity||100.28%|
|Return on Assets||31.72%|
|Return on Invested Capital||52.4%|
20,692 shares sold (8 transactions)
1,652 shares sold (4 transactions)
CEO: Jonathan Jay Mazelsky
Industry: Surgical and Medical Instrument Manufacturing
Analysts expect that IDEXX Laboratories, Inc. (NASDAQ:IDXX) will post sales of $779.98 million for the current quarter, Zacks reports. Four analysts have mad...Dakota Financial News, about 2 months ago
Ardevora Asset Management LLP lowered its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 15.4% during the 3rd quarter, according to the company in its mo...Dakota Financial News, about 2 months ago
Winthrop Advisory Group LLC reduced its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 7.2% during the 3rd quarter, according to the company...Dakota Financial News, about 2 months ago
Equities analysts forecast that IDEXX Laboratories, Inc. (NASDAQ:IDXX) will report earnings of $1.67 per share for the current fiscal quarter, Zacks reports....Dakota Financial News, about 2 months ago